No profile data available.
Acusphere, Inc. (ACUS) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in Watertown, United States.
It reported revenue of $2.67 million for fiscal year 2007, up 49.7% from fiscal year 2006, and net income of -$56.01 million. In Q3 2008 (the quarter ended September 30, 2008) revenue was $339,000, down 49.2% from a year before. Its market capitalization was $3.71 million as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2007; market data as of October 8, 2026.
Acusphere, Inc. operates as a specialty pharmaceutical company that develops and commercializes cardiovascular drugs. It offers Imagify (perflubutane polymer microspheres), a cardiovascular drug that evaluates myocardial perfusion and detects coronary artery disease. It provides Imagify as an injectable suspension.
Acusphere reported $2.67 million in revenue for fiscal year 2007, up 49.7% from $1.78 million in fiscal year 2006. In Q3 2008 revenue was $339,000.
$3.71 million as of October 8, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include LianBio (LIANY), Intellipharmaceutics International Inc. (IPCIQ), Oncology Pharma Inc. (ONPH), For The Earth Corp. (FTEG).